| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Sep 10, 2025 |
|||||||||
| Q2 FY25 | $0.33 | $0.14 | $3.10B | $3.08B |
NYSE |
||||
|
Oxford Industries
OXM
|
Q2 FY25 | $1.26 | $1.21 | $403.14M | $308.88M |
NYSE |
|||
|
Alliance Entertainment Holding
AENT
|
Q4 FY25 | $0.11 | $0.07 | $227.75M | $230.50M |
NASDAQ |
|||
|
Daktronics
DAKT
|
Q1 FY26 | $0.33 | $0.24 | $218.97M | $217.70M |
NASDAQ |
|||
|
Aviat Networks
AVNW
|
Q4 FY25 | $0.83 | $0.43 | $112.64M | $109.26M |
NASDAQ |
|||
|
Vince Holding
VNCE
|
Q2 FY25 | $0.38 | -$0.08 | $73.24M | $81.77M |
NASDAQ |
|||
|
Kewaunee Scientific
KEQU
|
- | $1.10 | - | $71.10M | - |
NASDAQ |
|||
|
Culp
CULP
|
Q1 FY26 | -$0.02 | -$0.12 | $50.69M | $57.50M |
NASDAQ |
|||
|
Anixa Biosciences
ANIX
|
- | -$0.07 | -$0.10 | - | - |
NASDAQ |
|||
|
Alzamend Neuro
ALZN
|
- | -$1.28 | -$3.69 | - | - |
NASDAQ |
|||
|
Streamline Health Solutions
STRM
|
Q1 FY26 | -$0.75 | - | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
